Insider filing · CRVS
Peter A. Thompson
Director
profile →
Corvus Pharmaceuticals, Inc.
CRVS · Healthcare · 3 filings in 24 months
ticker →
Peter A. Thompson sold $4.9M of Corvus Pharmaceuticals (CRVS)
Executed Jun 27 2025, disclosed Jul 1 2025, 4 days later.
Value, as filed
$4.9M
1,176,332 sh × $4.16
Executed
Jun 27 2025
the trade date, as filed
Disclosed
Jul 1 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
PTPeter A. Thompson (Director) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Sionna Therapeutics, Inc. (SION). The largest single filing was $22.9M of SION (510,583 sh across 3 lots, as filed), executed Apr 14.
The name
CRVSHealthcare · Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of product candidates that precisely t…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→